Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure.
about
Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOFA proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.Comparative proteome analysis of peripheral blood mononuclear cells in systemic lupus erythematosus with iTRAQ quantitative proteomics.Differential expression of serine-threonine kinase receptor-associated protein in patients with systemic lupus erythematosus.Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.YKL-40 expression in traumatic brain injury: an initial analysisNeuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.Systemic, local, and imaging biomarkers of brain injury: more needed, and better use of those already established?Statistical considerations of optimal study design for human plasma proteomics and biomarker discoverySILAC compatible strain of Pichia pastoris for expression of isotopically labeled protein standards and quantitative proteomics.Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartanAcute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord InjuryCurrent status of fluid biomarkers in mild traumatic brain injuryMaster redox regulator Trx1 upregulates SMYD1 & modulates lysine methylation.Differential proteomic analysis of respiratory failure in peripheral blood mononuclear cells using iTRAQ technology.Quantitative proteomics for identifying biomarkers for Rabies.Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury.Randomized trial to evaluate nutritional status and absorption of enteral feeding after brain death.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.Differential proteomics analysis of liver failure in peripheral blood mononuclear cells using isobaric tags for relative and absolute quantitation.Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery.Prediction of in-hospital mortality and morbidity using high-sensitivity C-reactive protein after burr hole craniostomy.Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage.Zeptomole detection of C-reactive protein in serum by a nanoparticle amplified surface plasmon resonance imaging aptasensor.Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury.Biomarkers in the clinical diagnosis and management of traumatic brain injury.Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.Serum amyloid A is increased in children with abusive head trauma: a gel-based proteomic analysis.Detection of C-reactive protein using nanoparticle-enhanced surface plasmon resonance using an aptamer-antibody sandwich assay.Effects of concussion on the blood–brain barrier in humans and rodents
P2860
Q28540277-3C1616F4-C741-40CF-AEE4-2C6A7663E260Q33514848-9DAC1FE3-9CAA-4F7B-A639-E25D14084EA0Q33759470-496EC0FB-BE6E-42FB-93C9-6EB0E4897F48Q33912357-E1251230-B074-49CA-8076-B658B0388CD9Q33945104-15182CFC-D371-4651-A8CD-27F5875D98BCQ34142567-E1ACAD9B-309A-4788-9D63-5A13CA496C77Q34193737-27638B2A-1DAE-43B4-B38A-762EC357FF74Q34989853-E108BB92-6F1A-4EBB-9B39-834CDACD3259Q35094550-C5D5694B-D5A1-45E3-BE8D-7CE18C253CF5Q35873957-38FB6239-DBBC-4441-B8ED-0169409FCB07Q35993587-B963FC2C-323B-4F5E-8EB6-37B59C8E754CQ36167581-0D41E66D-53C3-4B4A-9585-9CF9DEEBCCF8Q36263536-1D3E06C1-50AC-4CDC-B55D-CECADF7CE446Q36424343-5DDD04B9-0AC8-4F5B-B8E6-C53357524172Q36486897-95E62C0C-55AE-49E6-991B-9028EFDCADF5Q36824529-BDE90EF8-58AC-4122-A339-22F599065E70Q36863379-B1B9F9E4-976F-4E1A-987E-90D5876B3CB4Q37374156-FEAE24CD-7D45-4B22-90E3-A6DE3B5E6027Q37677399-CFC54862-E202-41A8-A9A7-DC1380575D08Q37691267-D294769E-AF44-41AB-AB60-A0A1E87A0F92Q37701236-FA7BFAC0-8B6E-45E8-9B78-83B5D9433B30Q38113215-B75C86E3-A9BE-44C5-A2F2-D5532CD4B17DQ39310566-CA78C8A1-D714-4066-BAA0-CED41119B9CDQ40024929-E6FB8ECE-00B1-4B0B-BFF2-22BB8806AC21Q40073817-7CF041DE-D571-4A10-B564-855E7F863701Q41598901-774AD833-0C28-420C-9EA7-529FC19BDA65Q45061432-78097137-C625-4A22-887C-99E86E61DDAFQ47421750-418C863F-168A-452A-BBA4-4021F5507989Q48658510-68B56F1B-D497-431D-8D39-A19C64EC7411Q48709585-DE244FD2-7A7E-4C9D-B518-E54F4C9C413FQ51470153-23E92480-CD6B-4706-B929-BC10F0128B8CQ59187790-993C6827-A6F6-4681-B154-3FD7C4A896A8
P2860
Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Identification of serum biomar ...... levated intracranial pressure.
@en
Identification of serum biomar ...... levated intracranial pressure.
@nl
type
label
Identification of serum biomar ...... levated intracranial pressure.
@en
Identification of serum biomar ...... levated intracranial pressure.
@nl
prefLabel
Identification of serum biomar ...... levated intracranial pressure.
@en
Identification of serum biomar ...... levated intracranial pressure.
@nl
P2093
P356
P1476
Identification of serum biomar ...... levated intracranial pressure.
@en
P2093
Alex Valadka
Anthony N Moore
Guy L Clifton
John B Redell
John Crommett
Pramod K Dash
Robert Levine
Robert T Funk
William P Dubinsky
P356
10.1089/NEU.2007.0386
P577
2008-02-01T00:00:00Z